Stockscreener 앱 받기
6.33
1.40%
-0.09
시간 외 거래:
6.32
-0.010
-0.16%
전일 마감가:
$6.42
열려 있는:
$6.49
하루 거래량:
194.32K
Relative Volume:
0.36
시가총액:
$227.00M
수익:
$59.63M
순이익/손실:
$-72.21M
주가수익비율:
-3.0143
EPS:
-2.1
순현금흐름:
$-30.85M
1주 성능:
-1.40%
1개월 성능:
-7.05%
6개월 성능:
+168.22%
1년 성능:
+43.21%
1일 변동 폭
$6.1673
$6.67
1주일 범위
$5.43
$6.7899
52주 변동 폭
$1.81
$8.06
908 디바이시스 Stock (MASS) Company Profile
명칭
908 Devices Inc
전화
978-729-4478
주소
645 SUMMER STREET, BOSTON
MASS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
6.33 | 235.82M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
908 디바이시스 Stock (MASS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-11-13 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-02-07 | 개시 | Stephens | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-01-12 | 개시 | Cowen | Outperform |
| 2021-01-12 | 개시 | SVB Leerink | Outperform |
| 2021-01-12 | 개시 | Stifel | Buy |
| 2021-01-12 | 개시 | William Blair | Outperform |
모두보기
908 디바이시스 주식(MASS)의 최신 뉴스
908 Devices Inc. (NASDAQ:MASS) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛
908 Devices Inc. (NASDAQ:MASS) Analysts Remain Bullish Despite Q2 Earnings Miss - AInvest
908 Devices Inc. Reports Strong Growth and Optimism - TipRanks
908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
908 Devices Raises Revenue Outlook and Reports 14% YoY Growth in Q2 2025 - AInvest
Repligen Corporation shares fall 2.74% intraday after 908 Devices Inc. acquired assets of KAF Manufacturing. - AInvest
908 Devices Inc. shares rise 3.47% intraday after acquiring assets of KAF Manufacturing. - AInvest
908 Devices Inc. (NASDAQ:MASS) Q2 2025 Earnings Call Transcript - Insider Monkey
908 Devices (MASS) Receives a Buy from William Blair - The Globe and Mail
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates - MSN
908 Devices 2025 Q2 Earnings Net Loss Widens 6% Despite Revenue Growth - AInvest
908 Devices Q2 2025 Earnings: Revenue Surpasses Estimates at $13M, EPS Misses at -$0.21 - AInvest
908 Devices Upgraded to Outperform by Leerink with $12 Price Target - AInvest
908 Devices Inc (MASS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising ... By GuruFocus - Investing.com Canada
908 Devices Inc. Reports Q2 Growth and Raises Outlook - TipRanks
908 Devices Inc (MASS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Rising Expenses - GuruFocus
908 Devices (MASS) Q2 Revenue Jumps 14% - The Globe and Mail
908 Devices (MASS) Q2 Revenue Jumps 14% - The Motley Fool
FRONTERA ENERGY CORPORATION ANNOUNCE DIVESTMENT OF NON-CORE ASSETS IN ECUADOR - The Globe and Mail
908 Devices Inc. acquired Assets of KAF Manufacturing Company, Inc for $2.8 million. - MarketScreener
908 Devices stock rating upgraded by Leerink Partners on forensics focus - Investing.com Nigeria
Contradictions Unveiled: 908 Devices' 2025Q2 Earnings Call Raises Questions on Revenue Growth and Market Opportunities - AInvest
908 Devices Q2 2025 Earnings Conference Call Highlights - AInvest
Transcript : 908 Devices Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: 908 Devices Q2 2025 revenue rises, stock slides - Investing.com
908 Devices Inc reports results for the quarter ended June 30Earnings Summary - TradingView
908 Devices Surpasses Revenue Estimates, Posts Q2 Loss of $0.18 per Share - AInvest
908 Devices Inc. SEC 10-Q Report - TradingView
908 Devices reports Q2 EPS (37c), consensus (14c) - TipRanks
908 Devices Reports Q2 Earnings: Revenue of $13M, Net Loss at $13.3M - AInvest
Chemical analysis tools maker 908 Devices Q2 revenue beats estimates, raises FY forecast - MarketScreener
908 Devices Reports Second Quarter 2025 Financial Results - TradingView
908 Devices earnings missed by $0.20, revenue topped estimates - Investing.com Canada
908 Devices Q2 revenue up 14% YoY, raises FY25 revenue outlook. - AInvest
908 Devices Raises 2025 Revenue Outlook, Reports 14% YoY Growth - AInvest
Press Release: 908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook - 富途牛牛
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook - The Globe and Mail
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025 - The Globe and Mail
Earnings To Watch: 908 Devices Inc (MASS) Reports Q2 2025 Result - Yahoo Finance
908 Devices appoints Dr. Brandi Vann, former US principal deputy assistant secretary for nuclear, chemical, and biological defense, to its board of directors - MarketScreener
908 Devices Appoints Dr. Brandi Vann to Board - TipRanks
908 Devices Inc. Appoints Brandi Vann to Its Board of Directors - MarketScreener
908 Devices Appoints Dr. Brandi Vann To Board - citybiz
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors - Yahoo Finance
Is 908 Devices Inc. stock overvalued or undervaluedInvest smarter and grow your wealth faster - Jammu Links News
What is the risk reward ratio of investing in 908 Devices Inc. stockUnlock powerful market analysis and alerts - Jammu Links News
What makes 908 Devices Inc. stock price move sharplyIdentify undervalued stocks poised to rally - Jammu Links News
Is 908 Devices Inc. a growth stock or a value stockOutstanding trading profits - Jammu Links News
Should I hold or sell 908 Devices Inc. stock in 2025Capitalize on emerging trends for profits - Jammu Links News
Published on: 2025-08-03 15:07:59 - Jammu Links News
When is 908 Devices Inc. stock expected to show significant growthIdentify undervalued stocks poised to rally - Jammu Links News
908 디바이시스 (MASS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):